Debt-to-equity of SQZ Biotechnologies Co from 30 Jun 2021 to 30 Sep 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
SQZ Biotechnologies Co quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 30 Sep 2023.
  • SQZ Biotechnologies Co Debt-to-equity for the quarter ending 30 Sep 2023 was 108%, a 10% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

SQZ Biotechnologies Co Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2023 108% +10% +10% 30 Sep 2023
Q2 2023 101% +12% +13% 30 Jun 2023
Q1 2023 100% +23% +30% 31 Mar 2023
Q4 2022 99% +32% +47% 31 Dec 2022
Q3 2022 98% +30% +44% 30 Sep 2022
Q2 2022 89% -24% -21% 30 Jun 2022
Q1 2022 77% 31 Mar 2022
Q4 2021 68% 31 Dec 2021
Q3 2021 68% 30 Sep 2021
Q2 2021 113% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.